InvaGen Pharmaceuticals Inc., a wholly-owned subsidiary of Cipla Limited, has announced a voluntary recall of one lot of Vigabatrin for Oral Solution, USP 500mg, to the consumer level in the USA. This recall comes after the discovery of seal integrity issues in the product packaging, which could lead to powder leakage from the pouches. The […]
In an important safety announcement, Cipla Limited revealed that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc., based in the USA, is conducting a voluntary recall of a specific lot of Vigabatrin for Oral Solution, USP 500mg. This decision to recall was made due to the discovery of seal integrity issues, which have led to the leakage […]
